Detalhe da pesquisa
1.
Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions.
Ann Oncol
; 28(9): 2248-2255, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28911086
2.
DNA repair pathways to regulate response to chemoradiotherapy in patients with locally advanced head and neck cancer.
Tumour Biol
; 37(10): 13435-13443, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27465548
3.
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies.
Ann Oncol
; 25(11): 2147-2155, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25164908
4.
Combining plasma-based biosources to predict treatment response in NSCLC patients.
Ann Oncol
; 29(9): 2022, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30010765
5.
Combining plasma-based biosources to predict treatment response in NSCLC patients.
Ann Oncol
; 29(9): 2018, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32138978
6.
Cancer immunotherapy of patients with HIV infection.
Clin Transl Oncol
; 21(6): 713-720, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446984
7.
Tracking MET de-addiction in lung cancer: A road towards the oncogenic target.
Cancer Treat Rev
; 60: 1-11, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843992
8.
Tubulin inhibitors in non-small cell lung cancer: looking back and forward.
Expert Opin Pharmacother
; 17(8): 1113-29, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26898217
9.
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis.
Sci Rep
; 6: 22982, 2016 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26961069
10.
Proteinuria and favourable clinical response in a patient receiving paclitaxel + bevacizumab for metastatic breast cancer.
Ann Oncol
; 21(8): 1729-1730, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20601370
11.
Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
Cancer Chemother Pharmacol
; 75(4): 821-7, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25702051
12.
A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
Cancer Chemother Pharmacol
; 69(5): 1345-52, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22349809
13.
A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
Cancer Chemother Pharmacol
; 70(1): 169-76, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22669571